Given that the majority of human CRCs contain APC or β-catenin mutations, and thus exhibit constitutive activation of the Wnt signalling pathway downstream of the LRP/Frizzled receptors, one might predict LGR5 modulation (and subsequent stability of Wnt receptors) to have negligible effects upon the behaviour of tumour cells. The gene discussed is APC; the disease is neoplasm.